The criminal investigation into alleged price-fixing in the UK’s pharmaceutical sector conducted by the UK’s Serious Fraud Office (SFO) is on the brink of collapse after the House of Lords ruled that price-fixing, of itself, was not a criminal offence under common law (this ruling was issued in the Norris case described above). The SFO’s investigation relates to the conduct that has allegedly taken place before 2003 when the Enterprise Act made price-fixing a statutory criminal offence in the UK; therefore, the SFO relies on common law and its case has been compromised by the House of Lords ruling. The SFO is now attempting to amend its indictment.